Comparisons of the effects of second-generation antipsychotics long-acting injections on treatment retention according to severity of patient condition.
There have been no naturalistic reports in Japan clarifying the difference of second-generation antipsychotics (SGA) long-acting injections (LAIs) on treatment retention according to severity of patient condition. This study aimed to investigate the difference in treatment retention between SGA LAIs according to severity of patient condition. This study demonstrated that, although AOM patients had better rates of treatment retention compared to PP and RLAI for mild cases, the reverse was true for moderate to severe cases. Because treatment retention rates can differ for each SGA LAI based on the severity of the patient's condition.